The Olayan Center for Cancer Vaccines at MSK
Pioneering science and transformative clinical trials to accelerate precision cancer vaccines as the next breakthrough cancer therapy

The History of Cancer Vaccines at MSK

The bold idea to harness the immune system to fight cancer began at Memorial Sloan Kettering Cancer Center (MSK) more than a century ago. In the past two decades, the pace of discovery has accelerated, as MSK breakthroughs have continued to push the frontier of immunotherapy.

Among the most exciting advances are vaccines that can treat cancer. The simple yet powerful notion that we can teach the immune system to seek and destroy cancer cells has long sparked the imaginations of cancer researchers around the world.

How Cancer Vaccines Work

Precision vaccines empower the patient’s own immune system to spot the unique genetic signature of their cancer. This allows vaccines to:

  • Unleash immune cells to attack cancer while sparing healthy cells
  • Be combined with other cancer therapies
  • Trigger a long-lasting immune response that can potentially prevent cancers from spreading or returning

MSK scientists have already published results from the first and only clinical trial in the world testing precision mRNA vaccines for pancreatic cancer.  These findings have encouraged us to investigate using vaccines to treat more people with pancreatic and other deadly cancers.  This work will now be accelerated thanks to a major gift.

Goals of The Olayan Center for Cancer Vaccines at MSK

The Olayan Center for Cancer Vaccines at MSK allows MSK to lead the field in developing cancer vaccines that target a wide range of cancers. Cancer vaccines are an essential part of MSK’s broader efforts to expand and improve immunotherapy options for people with cancer worldwide. The Olayan Center for Cancer Vaccines at MSK is named in recognition of the generous support of The Olayan Charitable Foundation, the FORTH Foundation, and MSK trustee Hutham Olayan.

There is more information below about access for patients, MSK’s clinical trials, innovation, access for patients, and the team leading this unprecedented effort to drive discoveries that will reduce suffering and save lives. 

Therapeutic Cancer Vaccines

Doctors use therapeutic cancer vaccines to treat cancer after it occurs rather than to prevent it.

They work by exposing the immune system to antigens – the specific molecules that are linked to a patient’s cancer. These vaccines can be customized for every patient, allowing precision targeting of each individual’s tumor.

They can:

  • Stop a tumor from growing or spreading
  • Destroy cancer cells still in the body after treatments
  • Keep cancer from coming back  

Learn more about cancer vaccines

VIDEO | 01:02

Therapeutic Cancer Vaccines: How They Work

Therapeutic cancer vaccines train the body to protect itself against its own damaged or abnormal cells — including cancer cells.
Video Details

Here’s how to get a cancer vaccine:

If you’re not an MSK patient: Please call 800-525-2225. Our Care Advisors will connect you to an MSK doctor. They can talk with you about whether a cancer vaccine clinical trial or approved cancer vaccine is right for you. If they’re not good options, our Care Advisors will help you find other cancer treatments at MSK.

If you’re a patient at MSK: Talk with your MSK doctor about whether a cancer vaccine clinical trial or approved cancer vaccine is right for you. A cancer vaccine may not the best choice for you. Your MSK doctor also can talk with you about other treatment options.

Learn More About Therapeutic Cancer Vaccine Clinical Trials at MSK. Refer to these trial numbers:


Kidney Cancer (24-109)
Lung Cancer (Non-Small Cell) (24-036) 
Melanoma (23-098) 
Neuroblastoma (23-198) 
Neuroblastoma  (21-206)
Pancreatic Cancer (23-136)

Therapeutic Cancer Vaccines Approved by the FDA

Advanced Prostate Cancer
Sipuleucel-T (Provenge®)

Early Stage Bladder Cancer
Bacillus Calmette-Guérin (BCG).
Nadofaragene firadonevec (Adstiladrin®)

Advanced Melanoma
T-VEC (Imlygic®)

The Olayan Center for Cancer Vaccines at MSK is a one-of-a-kind academic biohub, uniting critical scientific and clinical disciplines to achieve transformative breakthroughs for patients.
Vinod P. Balachandran, MD Director, The Olayan Center for Cancer Vaccines at MSK

Podcast

Harnessing the Body’s Immune System to Prevent and Treat Cancers

In this episode of MSK’s ’Cancer Straight Talk’ podcast, Dr. Vinod Balachandran discusses the difference between preventative and therapeutic vaccines, which cancers are treatable with vaccines, and how cancer vaccines will be used in the future.

Play the episode

person holding a phone listening to a podcast
MSK Cancer Vaccine News and Innovation
MSK physician-scientist Vinod Balachandran.
In Early-Phase Pancreatic Cancer Clinical Trial, Investigational mRNA Vaccine Induces Sustained Immune Activity in Small Patient Group
Learn how MSK researchers are deploying mRNA vaccines against pancreatic cancer.
Read more
Memorial Sloan Kettering Cancer Center Surgeon-Scientist, Vinod Balachandran, MD, Named to The Washington Post Next 50
Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce The Washington Post has named Vinod Balachandran, MD, surgeon-scientist and Director of The Olayan Center for Cancer Vaccines at MSK, to the inaugural edition of the Post Next 50.
Learn more
Research confirms a sound strategy for designing a therapeutic vaccine for pancreatic cancer.
Picking the Winners: Study Sheds Light on Possible Best Targets for Pancreatic Cancer Vaccine
Dr. Benjamin Greenbaum used computational biology to confirm a strategy for designing a therapeutic vaccine for pancreatic cancer.
Read more

Our Team
The Olayan Center for Cancer Vaccines at MSK (OCCV)

 

Vinod Balachandran
Vinod Balachandran

Director of Olayan CCV; Laboratory Head, Human Oncology and Pathogenesis Program; Hepatopancreatobiliary Surgeon

Benjamin Greenbaum
Benjamin Greenbaum

Co-Director, Neoantigen Discovery, Olayan CCV; Computational Oncologist, Epidemiology and Biostatistics

Zach Sethna
Zachary Sethna

Senior Scientist, Computational Innovation

Jayon Lihm
Jayon Lihm

Senior Computational Biologist

Ahhyun Moon
Ahhyun Moon

Software Engineer

Anusha Rai

Program Assistant

Erin Patterson

Senior Manager, Research & Strategy

Nicole Scagliola Niklaus
Nicole Scagliola Niklaus

Project Manager

Contact Us

Please contact us if you have questions about the center or are interested in collaborating with our team.

OCCV@mskcc.org
The Olayan Center for Cancer Vaccines at MSK
Memorial Sloan Kettering Cancer Center